Development of recombinant anti-TLR2 antibodies and PLGA nanoparticle-based gene therapy for the treatment of neuropathic pain
Fields of Study & Subjects
Immune Response and Inflammation
Monoclonal and Polyclonal Antibodies Research
Pain Mechanisms and Treatments
Publication details
- Journal / source
- Molecular Therapy
- Publication date
- 1 July 2026
- Language
- EN